Published in Obstet Gynecol on October 01, 2014
Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause (2015) 1.61
Compounded non-FDA-approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey. Menopause (2016) 1.43
Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA (2015) 1.36
Management of Menopausal Symptoms. Obstet Gynecol (2015) 0.85
Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule. Climacteric (2016) 0.80
Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries. Post Reprod Health (2016) 0.75
Prescribing of FDA-approved and compounded hormone therapy differs by specialty. Menopause (2016) 0.75
Long- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats. Am J Physiol Renal Physiol (2016) 0.75
Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends. Chem Res Toxicol (2016) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med (1992) 12.89
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA (2004) 7.68
Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med (2004) 6.42
Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst (2007) 6.08
Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med (1975) 5.33
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
Association of exogenous estrogen and endometrial carcinoma. N Engl J Med (1975) 3.89
Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med (1991) 3.53
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst (1995) 2.24
Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J (1980) 1.99
Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol (2007) 1.98
Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol (2006) 1.96
Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat (2001) 1.68
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol (2012) 1.67
Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev (2007) 1.67
Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol (1985) 1.42
Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003. Obstet Gynecol (2006) 1.40
Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol (1979) 1.39
Prolonged estrogen therapy in postmenopausal women. J Am Med Assoc (1959) 1.30
Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health (1988) 1.24
Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet (1979) 1.23
Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited. JAMA (1989) 1.20
Use of menopausal hormones in the United States, 1992 through June, 2003. Pharmacoepidemiol Drug Saf (2005) 1.18
Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control (2007) 1.16
Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA (1979) 1.13
Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol (1995) 1.07
Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol (2000) 1.05
Use of postmenopausal hormone therapy since the Women's Health Initiative findings. Pharmacoepidemiol Drug Saf (2005) 1.05
Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study . Menopause (2008) 1.01
A decline in breast-cancer incidence. N Engl J Med (2007) 1.01
Are women using postmenopausal estrogens? A community survey. Am J Public Health (1990) 1.00
Prevalence of estrogen or estrogen-progestin hormone therapy use. Obstet Gynecol (2003) 0.97
Characteristics of noncontraceptive hormone users. Prev Med (1988) 0.92
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 0.83
Recent patterns of hormone replacement therapy use in a large managed care organization. J Womens Health (1998) 0.82
Correlates of change in postmenopausal estrogen use in a population-based study. Am J Epidemiol (1986) 0.82
Epidemiology of exogenous estrogens. HSMHA Health Rep (1971) 0.82
Changes in postmenopausal hormone therapy use since 1988. Womens Health Issues (2007) 0.81
Breast cancer decline mirrors fall in hormone use, spurs both debate and research. J Natl Cancer Inst (2007) 0.78
Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med (2008) 6.35
Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol (2005) 5.12
Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA (2002) 4.72
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology (2007) 3.96
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol (2011) 3.22
Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol (2006) 2.77
Long-term use of aspirin and age-related macular degeneration. JAMA (2012) 2.72
From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol (2006) 2.67
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol (2011) 2.65
Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med (2011) 2.64
Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol (2013) 2.46
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
The Wisconsin Breast Cancer Epidemiology Simulation Model. J Natl Cancer Inst Monogr (2006) 2.27
Geocoding addresses from a large population-based study: lessons learned. Epidemiology (2003) 2.27
Tension-dependent regulation of microtubule dynamics at kinetochores can explain metaphase congression in yeast. Mol Biol Cell (2005) 2.27
Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology (2004) 2.22
Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst (2006) 2.19
Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol (2009) 2.18
Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med (2012) 2.17
Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev (2013) 2.14
The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis. J Rheumatol (2004) 2.13
The effects of lingual exercise in stroke patients with dysphagia. Arch Phys Med Rehabil (2007) 2.08
Effect of interhospital transfer on resource utilization and outcomes at a tertiary care referral center. Crit Care Med (2007) 2.01
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
The effects of lingual exercise on swallowing in older adults. J Am Geriatr Soc (2005) 1.95
Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med (2004) 1.87
Recruiting and training leadership through professional societies: a report from the American Society of Preventive Oncology Junior Members Interest Group. Cancer Epidemiol Biomarkers Prev (2006) 1.81
Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control (2008) 1.78
Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev (2009) 1.75
A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010. Obstet Gynecol (2012) 1.67
Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res (2013) 1.65
Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer (2010) 1.62
Cadmium exposure and breast cancer risk. J Natl Cancer Inst (2006) 1.61
Sedentary behavior, physical activity, and markers of health in older adults. Med Sci Sports Exerc (2013) 1.60
Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol (2012) 1.59
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59
Effects of birth order and maternal age on breast cancer risk: modification by whether women had been breast-fed. Epidemiology (2008) 1.56
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 1.56
Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Res Treat (2013) 1.53
Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer (2006) 1.48
The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology (2009) 1.47
Potential exposure to PCBs, DDT, and PBDEs from sport-caught fish consumption in relation to breast cancer risk in Wisconsin. Environ Health Perspect (2004) 1.47
Postoophorectomy estrogen use and breast cancer risk. Obstet Gynecol (2012) 1.46
Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Place of residence and primary treatment of prostate cancer: examining trends in rural and nonrural areas in Wisconsin. Urology (2013) 1.42
Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage (2002) 1.40
Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res (2006) 1.37
Quality of cancer registry data: findings from CDC-NPCR's Breast and Prostate Cancer Data Quality and Patterns of Care Study. J Registry Manag (2011) 1.35
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control (2003) 1.32
Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk. Proc Natl Acad Sci U S A (2007) 1.29
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol (2004) 1.28
Identifying geographic disparities in the early detection of breast cancer using a geographic information system. Prev Chronic Dis (2005) 1.25
Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.25
Health-related quality of life before and after a breast cancer diagnosis. Breast Cancer Res Treat (2007) 1.21
Early life factors in relation to breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2002) 1.20
Gene-environment interaction effects on the development of immune responses in the 1st year of life. Am J Hum Genet (2005) 1.19
Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology (2008) 1.19
The characteristics and training of professionals in cancer prevention and control: a survey of theAmerican Society for Preventive Oncology. Cancer Epidemiol Biomarkers Prev (2004) 1.18
Barriers and facilitators to implementing cancer survivorship care plans. Oncol Nurs Forum (2013) 1.18
Incidence of age-related cataract over a 15-year interval the Beaver Dam Eye Study. Ophthalmology (2008) 1.18
Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control (2006) 1.17
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev (2014) 1.17
Part-time medical practice: where is it headed? Am J Med (2005) 1.15
Model Convolution: A Computational Approach to Digital Image Interpretation. Cell Mol Bioeng (2010) 1.15
Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study. Ophthalmology (2013) 1.14
Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages. Proc Natl Acad Sci U S A (2005) 1.14
Trends in kidney transplantation rates and disparities. J Natl Med Assoc (2007) 1.14
Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev (2005) 1.14
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Dynamic interactions of a transcription factor with DNA are accelerated by a chromatin remodeller. EMBO Rep (2004) 1.12
Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children. J Allergy Clin Immunol (2009) 1.11
Social networks and quality of life among female long-term colorectal cancer survivors. Cancer (2003) 1.11
Ultrasound validation of maneuvers to increase internal jugular vein cross-sectional area and decrease compressibility. Am J Emerg Med (2009) 1.10
Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis (2007) 1.10
Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet (2007) 1.10
STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis (2004) 1.10
Association of obstructive sleep apnea risk with asthma control in adults. Chest (2010) 1.09
Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat (2011) 1.08
Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol (2008) 1.08
Prevalence of breast carcinoma in situ in the United States. JAMA (2009) 1.07
Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? Am J Epidemiol (2011) 1.07
Sleep duration and obesity in a population-based study. Sleep Med (2010) 1.06
Correlation of chromosomal instability, telomere length and telomere maintenance in microsatellite stable rectal cancer: a molecular subclass of rectal cancer. PLoS One (2013) 1.05
A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer. Breast Cancer Res (2005) 1.05
Acculturation and cigarette smoking among pregnant Hispanic women residing in the United States. Am J Public Health (2007) 1.05
Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology (2014) 1.05